StockGuide AI - assistant for market research — Feed

Analysts Goldman Sachs reiterate Apple (AAPL) as buy, citing strong product announcements and revenue growth potential

10/29/2026, 05:37 AM investing rating_growth Analysts: analysts, Goldman Sachs software Wintrust Financial Microsoft Palantir Technologies Alphabet Tesla Carvana Chevron Apple

Several major Wall Street firms have made significant calls on various stocks, highlighting strong earnings and growth potential for companies like Microsoft, ServiceNow, and Tesla, while downgrading Alphabet due to slowing growth.

Analysts Citizens downgraded Alphabet (GOOGL) to market perform following disappointing third-quarter results

10/29/2026, 04:37 AM investing rating_drop Analysts: analysts, Citizens Alphabet

Alphabet's disappointing third-quarter earnings report has raised concerns among investors about the company's growth prospects, particularly in its core search business amidst the ongoing AI revolution.

Analysts expect market movements as major economic indicators and corporate earnings reports approach

10/28/2026, 05:37 PM investing forecast Analysts: analysts finance software Rivian Caterpillar Chipotle Mexican Grill Microsoft Alphabet Merck

The article highlights key financial indicators and stock movements as the market prepares for the next trading session, emphasizing the importance of upcoming economic data and corporate earnings reports for investors.

Alphabet (GOOGL) Shares Drop Nearly 10% Following Disappointing Q3 Earnings Amid Concerns Over Advertising Revenue Shift

10/28/2026, 05:37 PM investing review ai internet Alphabet

Alphabet's disappointing third-quarter earnings report has raised concerns about the future of its advertising revenue as artificial intelligence begins to reshape user behavior and search habits.

Wall Street Shifts Focus to Tech Earnings and AI Recovery Following Fed’s Steady Interest Rates

10/28/2026, 03:37 PM investing review tech ai Microsoft Alphabet Invesco

Investors are shifting their focus from the Federal Reserve's decision to hold interest rates steady to the earnings reports from major tech companies, which are showing mixed results but overall positive trends in profit margins and stock performance.

Biotechnology Sector Thrives Amidst Sluggish IPO Market, Caution Advised for Investors

10/28/2026, 11:37 AM investing review biotech

The biotechnology sector is experiencing a surge in initial public offerings (IPOs), contrasting with a broader slowdown in the IPO market, but investors should remain cautious due to the high risks associated with biotech investments.

Analysts highlight Broadcom (AVGO) as a key beneficiary of Anthropic’s upcoming IPO amid rising AI optimism

10/28/2026, 10:37 AM investing review Analysts ai semiconductors Amazon Alphabet Broadcom

Anthropic's upcoming IPO has sparked renewed interest in artificial intelligence stocks, leading to significant gains in related sectors as investors position themselves ahead of the offering, which could be valued between $1.5 trillion and $2 trillion.

Analysts Guggenheim Securities initiate coverage of MSG Rangers (MSGR) and MSG Knickerbockers (MSGK) with buy ratings and significant upside potential

10/28/2026, 08:38 AM investing rating_growth Analysts: analysts, Guggenheim Madison Square Garden Sports

The recent spinoff of the New York Rangers and New York Knicks from Madison Square Garden Sports is expected to create significant value for shareholders, according to Guggenheim Securities, which has issued buy ratings for both teams with substantial price targets.

Analysts Bernstein expects upside for Robinhood Markets (HOOD) with $160 target price driven by prediction markets and new offerings

10/28/2026, 05:37 AM investing forecast Analysts: analysts, Bernstein finance Robinhood

Bernstein predicts significant growth for Robinhood Markets driven by emerging technologies and new products, setting a price target of $160, which suggests a potential upside of 69%. This outlook is particularly relevant as the company adapts to evolving market conditions and regulatory frameworks.

Analysts Jefferies upgraded Chemed (CHE) to Buy and raised target price to $620, expecting 22% upside

10/28/2026, 04:37 AM investing rating_growth Analysts: analysts, Jefferies

Jefferies has upgraded Chemed to a 'buy' rating and increased its price target to $620, indicating a potential 22% upside, following the company's strong third-quarter earnings that exceeded expectations. This upgrade reflects confidence in Chemed's recovery from recent operational challenges and its ability to regain a premium valuation.